UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design

Annals of surgical oncology, 2013-08, Vol.20 (8), p.2787-2795

2013

Volltextzugriff (PDF)

Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841

Journal of clinical oncology, 2012-01, Vol.30 (3), p.263-267

2012

Volltextzugriff (PDF)

Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

Journal of clinical oncology, 2011-11, Vol.29 (31), p.4105-4112

2011

Volltextzugriff (PDF)

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Journal of clinical oncology, 2015-08, Vol.33 (24), p.2617-2622

2015

Volltextzugriff (PDF)

Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy

Journal of clinical oncology, 2013-10, Vol.31 (29), p.3664-3672

2013

Volltextzugriff (PDF)

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

Journal of clinical oncology, 2007-04, Vol.25 (12), p.1539-1544

2007

Volltextzugriff (PDF)

Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer

JNCI : Journal of the National Cancer Institute, 2017-05, Vol.109 (5), p.djw272

2017

Volltextzugriff (PDF)

Molecular Markers Identify Subtypes of Stage III Colon Cancer Associated With Patient Outcomes

Gastroenterology (New York, N.Y. 1943), 2015-01, Vol.148 (1), p.88-99

2015

Volltextzugriff (PDF)

KRAS Codon 12 and 13 Mutations in Relation to Disease-Free Survival in BRAF-Wild-Type Stage III Colon Cancers from an Adjuvant Chemotherapy Trial (N0147 Alliance)

Clinical cancer research, 2014-06, Vol.20 (11), p.3033-3043

2014

Volltextzugriff (PDF)

Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147

JNCI : Journal of the National Cancer Institute, 2014-07, Vol.106 (7), p.1

2014

Volltextzugriff (PDF)

Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database

Journal of clinical oncology, 2016-03, Vol.34 (8), p.843-853

2016

Volltextzugriff (PDF)

MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer

Scientific reports, 2017-03, Vol.7 (1), p.43393-43393, Article 43393

2017

Volltextzugriff (PDF)

Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)

Clinical cancer research, 2015-12, Vol.21 (23), p.5294-5304

2015

Volltextzugriff (PDF)

Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer Patients

JNCI : Journal of the National Cancer Institute, 2015-10, Vol.107 (10), p.djv186

2015

Volltextzugriff (PDF)

Update on the optimal management of patients with colorectal liver metastases

Critical reviews in oncology/hematology, 2012-10, Vol.84 (1), p.59-70

Alberts, Steven R

2012

Volltextzugriff (PDF)

Intertumoral Heterogeneity of CD3 + and CD8 + T-Cell Densities in the Microenvironment of DNA Mismatch-Repair-Deficient Colon Cancers: Implications for Prognosis

Clinical cancer research, 2019-01, Vol.25 (1), p.125-133

2019

Volltextzugriff (PDF)

DPYD variants as predictors of 5-fluorouracil toxicity in adjuvant colon cancer treatment (NCCTG N0147)

JNCI : Journal of the National Cancer Institute, 2014-12, Vol.106 (12), p.1

2014

Volltextzugriff (PDF)

Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial

JAMA : the journal of the American Medical Association, 2012-04, Vol.307 (13), p.1383

2012

Volltextzugriff (PDF)

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

Journal of clinical oncology, 2004-01, Vol.22 (1), p.23-30

2004

Volltextzugriff (PDF)

Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7

Journal of clinical oncology, 2011-02, Vol.29 (4), p.421-427

2011

Volltextzugriff (PDF)

Gastric cancer in Alaska Native people: A cancer health disparity

World journal of gastroenterology : WJG, 2018-07, Vol.24 (25), p.2722-2732

2018

Volltextzugriff (PDF)

EUS-guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancer

Gastrointestinal endoscopy, 2017-07, Vol.86 (1), p.161-169

2017

Volltextzugriff (PDF)

Stool DNA Testing for Screening Detection of Colorectal Neoplasia in Alaska Native People

Mayo Clinic proceedings, 2016-01, Vol.91 (1), p.61-70

2016

Volltextzugriff (PDF)

Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group

Journal of clinical oncology, 2009-08, Vol.27 (23), p.3778-3785

2009

Volltextzugriff (PDF)

Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database

JNCI : Journal of the National Cancer Institute, 2021-04, Vol.113 (4), p.400-407

2021

Volltextzugriff (PDF)

1 – 25 von 983

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(893)
Mit Volltextzugriff
(830)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Innovation In Aging
(119)
Journal Of Clinical Oncology
(114)
Clinical Cancer Research
(17)
The New England Journal Of Medicine
(17)
Cancer
(16)
Jnci : Journal Of The National Cancer Institute
(16)
Cancer Research
(15)
Clinical Colorectal Cancer
(12)
Plos One
(12)
New England Journal Of Medicine
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design

Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841

Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer

Molecular Markers Identify Subtypes of Stage III Colon Cancer Associated With Patient Outcomes

KRAS Codon 12 and 13 Mutations in Relation to Disease-Free Survival in BRAF-Wild-Type Stage III Colon Cancers from an Adjuvant Chemotherapy Trial (N0147 Alliance)

Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147

Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database

MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer

Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)

Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer Patients

Update on the optimal management of patients with colorectal liver metastases

Intertumoral Heterogeneity of CD3 + and CD8 + T-Cell Densities in the Microenvironment of DNA Mismatch-Repair-Deficient Colon Cancers: Implications for Prognosis

DPYD variants as predictors of 5-fluorouracil toxicity in adjuvant colon cancer treatment (NCCTG N0147)

Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7

Gastric cancer in Alaska Native people: A cancer health disparity

EUS-guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancer

Stool DNA Testing for Screening Detection of Colorectal Neoplasia in Alaska Native People

Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group

Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database

Suchergebnisse filtern